The funding landscape for HIV in Asia and the Pacific.

Robyn M Stuart,David P Wilson,Braedon Donald,David Wilson,Eric Lief

doi:10.7448/ias.18.1.20004

Robyn M Stuart, David P Wilson + Show 3 more

Open Access

https://doi.org/10.7448/ias.18.1.20004

Copy DOI

Abstract

IntroductionDespite recent and robust economic growth across the Asia-Pacific region, the majority of low- and middle-income countries in the region remain dependent on some donor support for HIV programmes. We describe the availability of bilateral and multilateral official development assistance (ODA) for HIV programmes in the region.MethodsThe donor countries considered in this analysis are Australia, Canada, Denmark, France, Germany, Netherlands, Norway, Sweden, the United Kingdom and the United States. To estimate bilateral and multilateral ODA financing for HIV programmes in the Asia-Pacific region between 2004 and 2013, we obtained funding data from the Organisation for Economic Co-operation and Development Creditor Reporting System database. Where possible, we checked these amounts against the funding data available from government aid agencies. Estimates of multilateral ODA financing for HIV/AIDS were based on the country allocations announcement by the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) for the period 2014 to 2016.ResultsCountries in the Asia-Pacific region receive the largest share of aid for HIV from the Global Fund. Bilateral funding for HIV in the region has been relatively stable over the last decade and is projected to remain below 10% of the worldwide response to the epidemic. Bilateral donors continue to prioritize ODA for HIV to other regions, particularly sub-Saharan Africa; Australia is an exception in prioritizing the Asia-Pacific region, but the United States is the bilateral donor providing the greatest amount of assistance in the region. Funding from the Global Fund has increased consistently since 2005, reaching a total of US$1.2 billion for the Asia-Pacific region from 2014 to 2016.ConclusionsEven with Global Fund allocations, countries in the Asia-Pacific region will not have enough resources to meet their epidemiological targets. Prevention funding is particularly vulnerable and requires greater domestic leadership and coordination. Bilateral donors are still crucially important in the response to HIV throughout the Asia-Pacific region.

Highlights

Despite recent and robust economic growth across the Asia-Pacific region, the majority of low- and middle-income countries in the region remain dependent on some donor support for HIV programmes
Bilateral donors continue to prioritize official development assistance (ODA) for HIV to other regions, sub-Saharan Africa; Australia is an exception in prioritizing the Asia-Pacific region, but the United States is the bilateral donor providing the greatest amount of assistance in the region
International aid for HIV in the Asia-Pacific region, 2004 to 2013 Major sources of international aid for HIV The largest international contributors to HIV programmes in the Asia-Pacific region between 2004 and 2013 were the Global Fund and the US government, which together provided over 60% of all international funding to the region (Figure 2a, final bar)

Summary

Introduction

Despite recent and robust economic growth across the Asia-Pacific region, the majority of low- and middle-income countries in the region remain dependent on some donor support for HIV programmes. All low-income and most lower-middle-income countries in the Asia-Pacific region are heavily reliant on international funding for HIV programmes (Figure 1) This dependence has persisted despite robust economic growth across Asia and the Pacific over the past decade. This new funding model reflects an expectation on governments in the Asia-Pacific region to be less reliant on external aid and invest more of their own resources in the health and wellbeing of their populations [1]

Methods

Results

Discussion

Conclusion